MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

Foghorn Therapeutics Inc. (FHTX)

Foghorn Therapeutics Inc. (FHTX)

|||

Balance Sheets Overview

Current Ratio
336.20%
Quick Ratio
336.20%
Cash Ratio
134.60%
Debt to Asset Ratio
139.84%
Unit: Thousand (K) dollars
Assets Breakdown
    • Total current assets
    • Operating lease right-of-use ass...
    • Restricted cash
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Deferred revenue, net of current...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
68,080
87,663
80,876
89,334
Marketable securities
99,502
95,968
78,018
90,944
Restricted cash
0
1,250
1,250
1,250
Prepaid expenses and other current assets
2,464
3,183
3,091
2,589
Total current assets
170,046
188,064
163,235
184,117
Property and equipment, net
1,497
1,712
1,915
8,662
Restricted cash
2,000
2,000
2,000
2,000
Other assets
3
3
4
5
Operating lease right-of-use assets
29,847
30,388
30,949
10,178
Total assets
203,393
222,167
198,103
204,962
Accounts payable
3,207
3,317
4,266
3,212
Accrued expenses and other current liabilities
7,960
6,924
11,357
9,822
Operating lease liabilities
2,819
1,863
923
6,755
Deferred revenue
36,593
52,300
43,192
65,299
Total current liabilities
50,579
64,404
59,738
85,088
Operating lease liabilities, net of current portion
40,283
40,131
40,347
15,774
Deferred revenue, net of current portion
193,222
193,587
205,962
193,102
Other liabilities
350
453
556
656
Total liabilities
284,434
298,575
306,603
294,620
Common stock, 0.0001 par value 175,000,000 shares authorized at june30, 2026 and december31, 2025 58,714,272 shares issued and outstanding at june30, 2026 and 56,657,329 shares issued and outstanding at december31, 2025
6
6
6
6
Additional paid-in capital
578,620
576,061
523,937
521,115
Accumulated other comprehensive gain (loss)
-134
-133
24
24
Accumulated deficit
-659,533
-652,342
-632,467
-610,803
Total stockholders deficit
-81,041
-76,408
-108,500
-89,658
Total liabilities and stockholders deficit
203,393
222,167
198,103
204,962
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$99,502K (-21.09%↓ Y/Y)Cash and cashequivalents$68,080K (-6.19%↓ Y/Y)Prepaid expenses andother current assets$2,464K (-37.25%↓ Y/Y)Total current assets$170,046K (-16.58%↓ Y/Y)Operating leaseright-of-use assets$29,847K (174.48%↑ Y/Y)Restricted cash$2,000K (0.00%↑ Y/Y)Property and equipment,net$1,497K (-84.27%↓ Y/Y)Other assets$3K (-50.00%↓ Y/Y)Total assets$203,393K (-10.10%↓ Y/Y)Accumulated deficit-$659,533K (-10.85%↓ Y/Y)Accumulated othercomprehensive gain (loss)-$134K (-204.55%↓ Y/Y)Total liabilities andstockholders deficit$203,393K (-10.10%↓ Y/Y)Total stockholdersdeficit-$81,041K (-5.72%↓ Y/Y)Additional paid-in capital$578,620K (11.63%↑ Y/Y)Common stock, 0.0001par value...$6K (0.00%↑ Y/Y)Total liabilities$284,434K (-6.09%↓ Y/Y)Deferred revenue, net ofcurrent portion$193,222K (-6.58%↓ Y/Y)Total currentliabilities$50,579K (-34.98%↓ Y/Y)Operating leaseliabilities, net of current...$40,283K (129.90%↑ Y/Y)Other liabilities$350K (-53.76%↓ Y/Y)Deferred revenue$36,593K (-38.73%↓ Y/Y)Accrued expenses andother current...$7,960K (-7.05%↓ Y/Y)Accounts payable$3,207K (-3.46%↓ Y/Y)Operating leaseliabilities$2,819K (-54.36%↓ Y/Y)